PrimePath Regulatory was founded to meet a growing need for integrated, strategic, and science-driven regulatory expertise in an increasingly complex global environment. Built on decades of experience in regulatory affairs, medical and scientific writing, CMC, and nonclinical strategy, PrimePath was established to bridge the gap between development and approval — helping companies move efficiently from concept to market.
The firm’s origins trace to the leadership and vision of its founder,
Dr. Stephen J. Lombardi, whose career spans global submissions across the U.S., EU, and key international markets. Drawing on this foundation, PrimePath was designed as a lean, senior-led consultancy — delivering the agility of a focused team with the depth of global regulatory experience.
PrimePath Regulatory empowers biopharmaceutical innovators to navigate the global regulatory landscape with clarity, confidence, and purpose.
We combine strategic insight, scientific excellence, and collaborative execution to accelerate the development and approval of therapies that improve lives worldwide — transforming regulatory complexity into a clear path to success.
A robust CMC strategy is critical to regulatory success and smooth product advancement. At PrimePath Regulatory, we ensure that your manufacturing and quality data are presented with clarity, consistency, and full alignment to global regulatory expectations. From strategic planning to technical authoring, our experts support every stage of CMC development — helping you anticipate challenges, maintain compliance, and position your product for timely approval and successful commercialization.
Copyright © 2025 PrimePath Regulatory - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
